Skip to main content

Table 4 Relevant pathogens identified from respiratory specimens

From: Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study

  Total (n = 254) Adults (n = 182) Children (n = 72)
Bacteria, n (%) 66 (26.0) 54 (29.7) 12 (16.7)
Haemophilus influenzae 12 (4.7) 11 (6.0) 1 (1.4)
Klebsiella pneumoniae 8 (3.1) 6 (3.3) 2 (2.8)
Staphylococcus aureus 4 (1.6) 1 (0.5) 3 (4.2)
Escherichia coli 4 (1.6) 3 (1.6) 1 (1.4)
Pseudomonas aeruginosa 4 (1.6) 4 (2.2) 0 (0.0)
Streptococcus pneumoniae 3 (1.2) 2 (1.1) 1 (1.4)
Streptococcus pyogenes 3 (1.2) 2 (1.1) 1 (1.4)
Legionella pneumophila 3 (1.2) 3 (1.6) 0 (0.0)
Mycobacterium tuberculosis 3 (1.2) 3 (1.6) 0 (0.0)
Mycoplasma pneumoniae 1 (0.4) 0 (0.0) 1 (1.4)
 Other bacteria 21 (8.3) 19 (10.4) 2 (2.8)
Viruses, n (%) 119 (46.9) 54 (29.7) 65 (90.3)
 Rhinovirus A/B/C 33 (13.0) 16 (8.8) 17 (23.6)
 Influenza A virus 17 (6.7) 11 (6.0) 6 (8.3)
 Influenza B virus 4 (1.6) 0 (0.0) 4 (5.6)
 Adenovirus 14 (5.5) 4 (2.2) 10 (13.9)
 Bocavirus 1/2/3/4 9 (3.5) 0 (0.0) 9 (12.5)
 Respiratory syncytial virus A 8 (3.1) 4 (2.2) 4 (5.6)
 Respiratory syncytial virus B 6 (2.4) 5 (2.7) 1 (1.4)
 Parainfluenza virus 1 1 (0.4) 1 (0.5) 0 (0.0)
 Parainfluenza virus 2 1 (0.4) 0 (0.0) 1 (1.4)
 Parainfluenza virus 3 6 (2.4) 3 (1.6) 3 (4.2)
 Parainfluenza virus 4 5 (2.0) 2 (1.1) 3 (4.2)
 Human Metapneumovirus 5 (2.0) 2 (1.1) 3 (4.2)
 Enterovirus 3 (1.2) 0 (0.0) 3 (4.2)
 Coronavirus 229E 1 (0.4) 1 (0.5) 0 (0.0)
 Coronavirus NL63 2 (0.8) 1 (0.5) 1 (1.4)
 Coronavirus OC43 1 (0.4) 1 (0.5) 0 (0.0)
 Non respiratory viruses 3 (1.2) 3 (1.6) 0 (0.0)
Fungi, n (%) 10 (3.9) 9 (4.9) 1 (1.4)
 Pneumocystis jirovecii 6 (2.4) 6 (3.3) 0 (0.0)
 Other fungi 4 (1.6) 3 (1.6) 1 (1.4)
  1. Pathogens associated with mixed infections were counted individually